Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. (Q34507119)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. |
scientific article |
Statements
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin (English)
D Pfister
M R Cooper
R Cohen
B Burtness
M Bos
A Seidman
K Gunnett
J Falcey
V Anderson
H Waksal
J Mendelsohn
1 February 2000